Canada Excellence Research Chair in Neurogenetics and Translational Neuroscience
Dr. Donald Rix B.C. Leadership Chair in Genetic Medicine
Professor, Medical Genetics, University of British Columbia (UBC)
An ambitious researcher, Dr. Matthew Farrer has made several influential discoveries in neurogenetics, and is critically acclaimed for his work on the genetics of Parkinson’s disease. Before accepting his position as Canada Excellence Research Chair in Neurogenetics and Translational Neuroscience at UBC, Dr. Farrer was a professor of molecular neuroscience and Director of the Division of Neurogenetics, the Transgenic Core Facility, and several neurogenetics laboratories at Mayo Clinic, Jacksonville, Florida.
Dr. Farrer holds a PhD in human genetics from Imperial College London, United Kingdom, and a bachelor’s degree in biochemistry from King’s College London, UK. His thesis studies focused on brain disorders, namely age-associated cognitive dysfunction in Down syndrome, and the complex trait genetics of trisomy 21. He was also a postdoctoral fellow in medical and community genetics at the Kennedy-Galton Centre of Medical and Community Genetics, St. Mark’s Hospital, Harrow, UK.
His current research interests are age-related neurodegenerative disorders, with a focus on the molecular genetics and functional modeling of movement disorders, including Parkinson’s disease and Lewy body dementia.